PET used to image β-amyloid levels in patients with Alzheimer's disease

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1356 / 1356
页数:1
相关论文
共 50 条
  • [31] Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
    Alcolea, Daniel
    Pegueroles, Jordi
    Munoz, Laia
    Camacho, Valle
    Lopez-Mora, Diego
    Fernandez-Leon, Alejandro
    Le Bastard, Nathalie
    Huyck, Els
    Nadal, Alicia
    Olmedo, Veronica
    Sampedro, Frederic
    Montal, Victor
    Vilaplana, Eduard
    Clarimon, Jordi
    Blesa, Rafael
    Fortea, Juan
    Lleo, Alberto
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (09): : 1815 - 1824
  • [32] A European multicentre PET study of fibrillar amyloid in Alzheimer's disease
    Nordberg, Agneta
    Carter, Stephen F.
    Rinne, Juha
    Drzezga, Alexander
    Brooks, David J.
    Vandenberghe, Rik
    Perani, Daniela
    Forsberg, Anton
    Langstrom, Bengt
    Scheinin, Noora
    Karrasch, Mira
    Nagren, Kjell
    Grimmer, Timo
    Miederer, Isabelle
    Edison, Paul
    Okello, Aren
    Van Laere, Koen
    Nelissen, Natalie
    Vandenbulcke, Mathieu
    Garibotto, Valentina
    Almkvist, Ove
    Kalbe, Elke
    Hinz, Rainer
    Herholz, Karl
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 104 - 114
  • [33] Negative Amyloid PET Imaging in a Patient With Probable Alzheimer's Disease
    Hellwig, Sabine
    Huell, Michael
    Meyer, Philipp T.
    CLINICAL NUCLEAR MEDICINE, 2011, 36 (12) : 1120 - 1121
  • [34] Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers
    S. M. Landau
    B. A. Thomas
    L. Thurfjell
    M. Schmidt
    R. Margolin
    M. Mintun
    M. Pontecorvo
    S. L. Baker
    W. J. Jagust
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1398 - 1407
  • [35] Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease
    Wang, YM
    Klunk, WE
    Debnath, ML
    Huang, GF
    Holt, DP
    Shao, L
    Mathis, CA
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 24 (01) : 55 - 62
  • [36] PET amyloid-beta imaging in preclinical Alzheimer's disease
    Vlassenko, Andrei G.
    Benzinger, Tammie L. S.
    Morris, John C.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2012, 1822 (03): : 370 - 379
  • [37] Alzheimer's disease in Down Syndrome: a FDG and Amyloid PET study
    Camacho, V.
    Fernandez-Leon, A.
    Sampedro, F.
    Carmona-Iragui, M.
    Lopez, D.
    Vilaplana, E.
    Fortea, J.
    Videla, S.
    Lleo, A.
    Blesa, R.
    Carrio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S119 - S119
  • [38] Toxicity of β-amyloid vaccination in patients with Alzheimer's disease
    Imbimbo, BP
    ANNALS OF NEUROLOGY, 2002, 51 (06) : 794 - 794
  • [39] Amyloid Structures from Alzheimer's Disease Patients
    Rienstra, Chad M.
    STRUCTURE, 2013, 21 (10) : 1722 - 1723
  • [40] Reduced cerebrospinal fluid estradiol levels are associated with increased β-amyloid levels in female patients with Alzheimer's disease
    Schönknecht, P
    Pantel, J
    Klinga, K
    Jensen, M
    Hartmann, T
    Salbach, B
    Schröder, J
    NEUROSCIENCE LETTERS, 2001, 307 (02) : 122 - 124